Between the Biotech Waves
Episodes
S2 E7: A Between the Biotech Waves Conversation with Bobby Gaspar
02 May 2025
Contributed by Lukas
Today’s episode features a remarkable leader in the field of gene therapy, Dr. Bobby Gaspar. With over 25 years of experience as a physician and sci...
S2 E6: A Between the Biotech Waves Conversation with Steve Paul
25 Apr 2025
Contributed by Lukas
I am thrilled to welcome Steve Paul to Between the Biotech Waves.With nearly 50 years of experience as a physician-scientist, Steve has made significa...
S2 E5: A Between the Biotech Waves Conversation with Kent Rogers
17 Apr 2025
Contributed by Lukas
Today, I are excited to welcome Kent Rogers, the Chief Executive Officer of EveryONE Medicines. Kent brings a wealth of experience to his new role, ha...
Between the Biotech Waves - Sound Bite - Bill Hicks Co-Chair Life Sciences Practice Mintz
16 Apr 2025
Contributed by Lukas
Sound Bite with Bill Hicks looking at the market and financing in real time.
Between the Biotech Waves - Sound Bite - Paul Matteis Equity Analyst Stifel
08 Apr 2025
Contributed by Lukas
Welcome to a Between the Biotech Waves sound bite, a short podcast to provide insight into the rapidly changing biotech environment - I am pleased to ...
S2 E4: A Between the Biotech Waves Conversation with Dan Lynch
27 Feb 2025
Contributed by Lukas
In this episode, I am thrilled to welcome Dan Lynch, an Executive Venture Partner at Google Ventures and a seasoned leader in the biotechnology sector...
S2 E3: A Between The Biotech Waves Conversation with Stan Crooke, Ionis & N-Lorem Founder
20 Feb 2025
Contributed by Lukas
In today's episode, I am honored to welcome Stanley Crooke, the founder and CEO of Ionis Pharmaceuticals the first and leading antisense oligonuc...
S2 E2: A Between the Biotech Waves Conversation with Peter Barrett
31 Jan 2025
Contributed by Lukas
Welcome to ‘Between the Biotech Waves,’ the podcast where we navigate the dynamic world of biotechnology and explore the minds driving its innovat...
S2 Episode 1: A conversation with Matt Porteus
24 Jan 2025
Contributed by Lukas
Now that JPM '25 is behind us, where the weather was great but the mood was somber, back to podcasting!Welcome back to 'Between the Biotech ...
Episode 35: A Between the Biotech Waves Conversation with Mike Curtis, President & CEO of eGenesis
02 Jul 2024
Contributed by Lukas
Welcome back to Between the Biotech Waves. I am sorry for the lack of episodes over the past few months, unfortunately life threw me a curve ball that...
Episode 33: A Between the Biotech Waves conversation with Eliot Forster, xCEO of F-star Therapeutics
19 Jul 2023
Contributed by Lukas
Today I am talking to Eliot Forster xCEO of F-star Therapeutics.Eliot was at helm of the company as they reversed merged into Springbank Pharmaceutica...
Episode 32: The Triplet Therapeutics story, from concept to birth, life & death.
19 Jul 2023
Contributed by Lukas
Today we have an unusual (& long) podcast where we talk to key members of the Triplet Therapeutics management team. Triplet was founded to develop...
Episode 31: A Between the Biotech Waves Conversation with Tim Yu
02 Jul 2023
Contributed by Lukas
Today we are talking to Tim Yu. Tim is attending physician at the division of genetics and genomics at Boston Children’s Hospital and assoc prof of...
Episode 30: A Between the Biotech Waves conversation with Barry Greene, CEO of Sage Therapeutics
02 Jul 2023
Contributed by Lukas
Today we are talking to Barry Greene, CEO of Sage Therapeutics. Barry has had an amazing career spanning over 30 years in the biotech industry. Prior ...
Episode 29: A Between the Biotech Waves conversation with Joel Marcus, Founder & Exec Chair of Alexandria Real Estate
16 Jun 2023
Contributed by Lukas
Today we are talking to Joel Marcus. He has shaped the life sciences industry through ARE from the buildings we use to venture and fund investing. His...
Episode 28 A Between the Biotech Waves Conversation with Rachel Meyers
16 Jun 2023
Contributed by Lukas
Today we are talking to Rachel Meyers. Rachel was most recently the CSO of Faze Medicines a company she launched with TRV to focus on the regulation o...
Episode 27 A Between the Biotech Waves Conversation with Aoife Brennan, CEO of Synlogic
26 Apr 2023
Contributed by Lukas
Today we are talking to Aofie Brennan, president and CEO of Synlogic. Aoife was trained as a doctor at Trinity College Dublin following which she move...
Episode 26: A Between the Biotech Waves conversation with Drew Weissman
05 Feb 2023
Contributed by Lukas
Today we are talking to Drew Weissman. Drew is the Roberts Family Professor in Vaccine Research at Perelman School of Medicine and Director of the Pen...
Episode 25: A Between the Biotech Waves conversation with Rodolphe Barrangou, the Todd R Klaenhammer Distinguished Professor at NC State University.
03 Feb 2023
Contributed by Lukas
Today we are talking to Rodolphe Barrangou. Rodolphe is the Todd R Klaenhammer Distinguished Professor at NC State University. He is a scientist entre...
Episode 24: A Between the Biotech Waves conversation with John Hoffman, managing director & head of healthcare equity capital markets at Credit Suisse
08 Jan 2023
Contributed by Lukas
I am delighted to welcome back John Hoffman to Between the Biotech Waves. John is managing director & head of healthcare equity capital markets at...
Episode 23: A Between the Biotech Waves conversation with Jim Birchenough, Vice Chair of Wells Fargo Biopharmaceutical Inv Banking
08 Jan 2023
Contributed by Lukas
I am delighted to welcome back Jim Birchenough to Between the Biotech Waves. Jim is Vice Chair Wells Fargo Biopharmaceutical Investment Banking. In 20...
A Between the Biotech Waves Conversation with Jeremy Levin, Chair & CEO of Ovid Therapeutics
01 Jan 2023
Contributed by Lukas
Today we are talking to Jeremy Levin. Jeremy is chairman and CEO of Ovid Therapeutics, focused on rare and orphan disease of the CNS. He is the immedi...
Episode 21 A Between the Biotech Waves conversation with Laksh Aithani Co-founder & CEO of Charm Therapeutics
21 Dec 2022
Contributed by Lukas
Today we are talking to Laksh Aithani, Co-founder and CEO of Charm Therapeutics. Laksh is a scientist turned entrepreneur. He received his degree in N...
Episode 20: A Between the Biotech Waves conversation with Tom Barnes, CEO of ORNA Therapeutics
25 Oct 2022
Contributed by Lukas
Today we are talking to Tom Barnes. Tom is CEO of Orna Therapeutics, a circular RNA focused biotech developing in situ CAR therapeutics. Orna recently...
Episode 19: A Between the Biotech Waves Conversation with JeanFrancois Formela, Partner at Atlas Venture & multi-biotech company founder
15 Oct 2022
Contributed by Lukas
Today we are talking to JeanFrancois Formela. I have known JF for over 2 decades having worked with him at Atlas in building multiple biotech companie...
Episode 18: A Between the Biotech Waves conversation with Ram Aiyer, CEO of RNA base editing company Korro Bio
10 Oct 2022
Contributed by Lukas
Today we are talking to Ram Aiyer. Ram is CEO of Korro Bio, an RNA base editing company focused on co-opting ADAR, a naturally present editing system ...
Episode 17: A Between the Biotech Waves conversation with Regina Jorgensen, Director of the Maria Mitchell Observatory.
01 Oct 2022
Contributed by Lukas
In this episode we discuss the formation and evolution of galaxies, our expanding universe, the big bang, the source of fast radio bursts, the James W...
Episode 16: A Between the Biotech Waves conversation with Abraham Heifets CEO of Atomwise
29 Sep 2022
Contributed by Lukas
Today we talk to Abe Heifets, CEO of Atomwise, a biotech company focusing on the utilization of AI for drug discovery. Atomwise recently (post this re...
Episode 15: A Between the Biotech Waves Conversation with Rodger Novak and Shaun Foy, co-founders with Emmanuelle Charpentier of CRISPR Therapeutics
13 Sep 2022
Contributed by Lukas
Discussing the formation of CRISPR Tx, the positives, negatives and everything in between. This is the first time all three of us reconnected since ou...
Episode 14: A Between the Biotech Waves Conversation with Paul Matteis, Managing Director of Biotechnology Equity Research at Stifel
01 Sep 2022
Contributed by Lukas
Episode 13: A Between the Biotech Waves Conversation with Vic Myer, President and CSO at Chroma Medicine
25 Aug 2022
Contributed by Lukas
Today we talk to Vic Myer, xChief Technology Officer at Editas, currently President and CSO at Chroma Medicine. We discuss the state of genome editing...
Episode 12: A Between the Biotech Waves conversation with Geoff Meacham, Managing Director of Equity Research at Banc of America covering Biotechnology and Major Pharmaceuticals in the US.
18 Aug 2022
Contributed by Lukas
Episode 11: A Between the Biotech Waves conversation with Prof Robert Langer. In this episode we discuss nanoparticle delivery systems and the evolution of drug discovery.
18 Aug 2022
Contributed by Lukas
Episode 10: A Between the Biotech Waves Conversation with Eric Topol focusing on COVID & AI in healthcare
27 Jul 2022
Contributed by Lukas
In this episode we are talking to Prof Eric Topol. Eric is a cardiologist by training, a basic scientist in the areas of personalized genomic medicine...
Episode 9: A Between the Biotech Waves Conversation with Yaron Werber, MD of Healthcare Biotechnology at Cowen.
27 Jul 2022
Contributed by Lukas
Today we are talking to Yaron Werber. Yaron is Managing Director of Healthcare Biotechnology at Cowen, he has over 20 years of experience as a researc...
Episode 7 A conversation with John Hoffman Managing Director & head of Healthcare ECM at Credit Suisse
22 Jun 2022
Contributed by Lukas
A Between the Biotech Waves conversation with John Hofffman, managing director & head of healthcare equity capital markets at Credit Suisse. John ...
Episode 8 John Leonard CEO of Intellia Therapeutics
21 Jun 2022
Contributed by Lukas
A Between the Biotech Waves conversation with John Leonard, CEO of Intellia Therapeutics. John has over 30 years of experience in drug research & ...
A Between The Biotech Waves Conversation With Sumit Khedekar, Head of Healthcare of the Americas Investment Banking at Citi
09 Jun 2022
Contributed by Lukas
A discussion of the current market volatility and options for public biotech companies with Sumit Khedekar, Head of Healthcare Investment Banking at C...
A Between The Biotech Waves Conversation With Jim Birchenough, Vice Chair Wells Fargo Biopharmaceutical Investment Banking
09 Jun 2022
Contributed by Lukas
A discussion of the current market volatility and options for public biotech companies with Jim Birchenough Vice Chair Wells Fargo Biopharmaceutical I...
A Between The Biotech Waves Conversation With William Hicks, Co-Chair of Securities & Capital Markets Mintz Levin
09 Jun 2022
Contributed by Lukas
Today I talk to William Hicks, co-chair of securities and capital markets at Mintz Levin. We discuss the state of the capital markets, financing optio...
A Between The Waves Conversation with Julia Vitarello, the mother of Mila and co-developer of Milasen
26 May 2022
Contributed by Lukas
A conversation with Julia Vitarello, founder of Mila's Miracle Foundation and co-founder of the N=1 Collaborative. Julia, in partnership with Dr ...
A Between The Biotech Waves Conversation with Sek Kathiresan, founder & CEO of Verve Therapeutics
26 May 2022
Contributed by Lukas
A Conversation With Sek Kathiresan MD, founder and CEO of Verve Therapeutics
A Between The Waves Conversation With Rich Ross, Technical Analyst at Evercore
20 May 2022
Contributed by Lukas